Diagnostic, prognostic and therapeutic role of B-type natriuretic peptide in heart failure Kalp yetersi̇zli̇ǧi̇ tani, tedavi̇ ve prognozunun beli̇rlenmesi̇nde B-ti̇pi̇ natri̇üreti̇k pepti̇di̇n yeri̇
Turk Kardiyoloji Dernegi Arsivi, cilt.31, sa.8, ss.458-465, 2003 (Scopus)
- Yayın Türü: Makale / Derleme
- Cilt numarası: 31 Sayı: 8
- Basım Tarihi: 2003
- Dergi Adı: Turk Kardiyoloji Dernegi Arsivi
- Derginin Tarandığı İndeksler: Scopus
- Sayfa Sayıları: ss.458-465
- Anahtar Kelimeler: B-type natriuretic peptide, Heart failure, Nesiritide
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
B-type natriuretic peptide (BNP) is a cadiac neurohormone specifically synthesised in and secreted from the ventricles in response to elevations of end-diastolic pressure and volume. It represents a favorable side of neurohormonal activation with its diuretic, natriuretic and vasodilator properties. Concentrations of BNP are increased in chronic heart failure and correlate with the severity and functional capacity, of the patient. Measurement of BNP may be useful in distinguishing between cardiac and noncardiac causes of acute dyspnea. It is also suggested as a screening method for left ventricular systolic dysfunction in groups at high risk such as those with coronary heart disease, hypertension, diabetes or other vascular diseases. In patients with congestive heart failure, BNP is an independent predictor of long-term morbidity and mortality. On the other hand, repeated measurements of BNP might be used to evaluate the efficacy of therapy for heart failure. Nesiritide, a recombinant human BNP, may have an important role in the management of heart failure, especially in patients with acute decompensated heart failure. In this article, we reviewed the studies evaluating the diagnostic, prognostic and thearapeutic role of BNP in patients with heart failure.